Standout Papers

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis 2003 2026 2010 2018 2.1k
  1. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis (2003)
    Laurent Sandrin, Sylvain Yon et al. Ultrasound in Medicine & Biology

Citation Impact

Citing Papers

Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
2010
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
2002
NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States
2002
Hepatocellular carcinoma screening in patients waiting for liver transplantation: A decision analytic model
2003
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan
2001
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
2001
Hepatocellular carcinoma
2003 Standout
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis
2011
Elastography: history, principles, and technique comparison
2015
Surveillance for Hepatocellular Carcinoma and Early Diagnosis
2007
Hepatocellular carcinoma
2018 Standout
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Management of patients with chronic hepatitis C infection
2006
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography†
2009
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients
2007
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
2008
The treatment of chronic hepatitis C with peginterferon alfa-2a (40kDa) plus ribavirin in haemodialysed patients awaiting renal transplant
2007
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study
2005
Renal ultrasound elastography
2013
Semiannual and Annual Surveillance of Cirrhotic Patients for Hepatocellular Carcinoma: Effects on Cancer Stage and Patient Survival (Italian Experience)
2002
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2019
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
2014
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
1996
Screening for hepatocellular carcinoma
1998
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
2002
Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage
2007
Screening for hepatocellular carcinoma
1999
The biology and function of fibroblasts in cancer
2016 Standout
Hepatocellular carcinoma
2012 Standout
Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care
2018
Risk Assessment of Hepatitis B Virus–Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan) σ
2010
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
2010
Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement
2015
Screening for hepatocellular carcinoma
2005
Liver biopsy†
2008
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
2007
Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C
2010
Acute viral hepatitis increases liver stiffness values measured by transient elastography
2007
Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles
2010
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography - a randomised study
2013
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis
2003
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
2015
A new prognostic classification for predicting survival in patients with hepatocellular carcinoma
1999
The NAFLD fibrosis score
2007 Standout
Non invasive evaluation of portal hypertension using transient elastography
2011
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Liver Transplantation for Hepatocellular Carcinoma
2008
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
1996
Non-alcoholic fatty liver disease
2021 Standout
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Crohn's disease
2016 Standout
Sepsis and septic shock
2018 Standout
What challenges must be overcome before ultrasound elasticity imaging is ready for the clinic?
2011
Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis
2009
Mechanisms of Hepatic Fibrogenesis
2008 Standout
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®
2011
Risk Assessment of Hepatocellular Carcinoma in Chronic Hepatitis C Patients by Transient Elastography
2008
Chronic hepatitis B
2007 Standout
Treatment of hepatocellular carcinoma in patients with cirrhosis
1997
Diagnosis of liver fibrosis by transient elastography (FibroScan) and non‐invasive methods in Crohn's disease patients treated with methotrexate
2006
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Screening for hepatocellular carcinoma in cirrhosis
2003
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
2003
Impact of Surveillance on Survival of Patients With Initial Hepatocellular Carcinoma: A Study From Japan
2006
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma
2015
American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases
2017
Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study
2010
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡
2007
Efficacy of non-invasive elastometry on staging of hepatic fibrosis
2004
Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study
2014
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Hepatitis C and hepatocellular carcinoma
1997
Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: Matched case-control study, pathological analysis, and pathogenetic hypothesis
1997
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
2015
Ultrasound elastography: Principles and techniques
2013
Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
2006
Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications
2007
Des–Gamma Carboxyprothrombin Can Differentiate Hepatocellular Carcinoma From Nonmalignant Chronic Liver Disease in American Patients
2003
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
2016
Shear-Wave Elastography for the Estimation of Liver Fibrosis in Chronic Liver Disease: Determining Accuracy and Ideal Site for Measurement
2014
New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver
2011
Assessment of Liver Fibrosis with 2-D Shear Wave Elastography in Comparison to Transient Elastography and Acoustic Radiation Force Impulse Imaging in Patients with Chronic Liver Disease
2015
Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.
1998
Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography
2008
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
2018
Efficacy of a surveillance program for early detection of hepatocellular carcinoma
1996
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Non-invasive evaluation of liver fibrosis using transient elastography
2008
Molecular MRI of collagen to diagnose and stage liver fibrosis
2013
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C
2013
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma
2012
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study
2012
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Noninvasive Measures of Liver Fibrosis
2006
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
2000
Hepatocellular Carcinoma
2011 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C
2004
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
2009
Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care
2012
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
2009
Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis
2012
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Do We Still Need a Liver Biopsy? Are the Serum Fibrosis Tests Ready for Prime Time?
2006
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
2004
Replication of hepatitis C virus
2007 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
2001
Hepatocellular Carcinoma
2019 Standout
Evidence supporting laparoscopic major hepatectomy
2016
Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
2015
Noninvasive markers of hepatic fibrosis: Are they ready for prime time in the management of HIV/HCV co-infected patients?
2005
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus–related cirrhosis
2001
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients
2013
Screening for liver cancer: results of a randomised controlled trial in Qidong, China
2003
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
1998
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study
2014
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C
2003
Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 2, Diagnostic Performance, Confounders, and Future Directions
2015
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
Surveillance for hepatocellular carcinoma
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
2015
Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
2004
AASLD position paper: Liver biopsy
2008
Liver organ allocation for hepatocellular carcinoma: Are we sure?
2003
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Serum ?-L-fucosidase activity and early detection of hepatocellular carcinoma
1998
HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets
2004
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques
2015
Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography–defined subclinical cirrhosis
2015

Works of Frédéric Mal being referenced

Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions
2001
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
2004
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis
2003 Standout
Totally laparoscopic right hepatectomy
2007
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
1994
Prognostic Factor Analysis in Advanced Gastric Cancer Patients Treated with Hydroxyurea, Leucovorin, 5-Fluorouracil, and Cisplatin (HLFP Regimen)
2003
Rankless by CCL
2026